fenoldopam mesylate - Profile
✉ Email this page to a colleague
What are the generic drug sources for fenoldopam mesylate and what is the scope of patent protection?
Fenoldopam mesylate
is the generic ingredient in two branded drugs marketed by Hospira, Hikma, Luitpold, Sandoz, and Teva Parenteral, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Summary for fenoldopam mesylate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 5 |
| NDAs: | 5 |
US Patents and Regulatory Information for fenoldopam mesylate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | CORLOPAM | fenoldopam mesylate | INJECTABLE;INJECTION | 019922-001 | Sep 23, 1997 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 076582-001 | Oct 12, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Luitpold | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 076656-001 | Dec 1, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 077155-001 | Feb 15, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Parenteral | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 077826-001 | Mar 7, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
